Skip to content

Recovery of Respiratory System in COVID-19 Patients

Tracking the Recovery of Respiratory Physiology in COVID-19 Patients a Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04954222
Enrollment
80
Registered
2021-07-08
Start date
2022-02-14
Completion date
2024-01-08
Last updated
2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

The purpose of this study is to determine the effects of the clinical course of treatment as well as long-term symptoms of COVID-19 on respiratory function, exercise capacity, and quality of life.

Detailed description

This study will be completed over 4 sessions at the Mayo Clinic at either the Scottsdale Arizona or Rochester Minnesota locations. You will be asked to complete a series of questionnaires, lung function tests, and exercise tests at two time points: ≥ 28 days post diagnosis and 4-6 months after the first laboratory visit. All visits will take approximately 2 hours. During visits 1 and 3 a series of questionnaires as well as breathing tests, and an exercise test will be completed on a stationary bike. You will also be asked to breathe a gas mixture out of a bag to obtain measures of gas movement and sensitivity. During visits 2 and 4 you will complete an exercise test on a stationary bike to measure changes from the previous exercise test and a chest scan.

Interventions

None listed

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Have a documented positive qRT-PCR for SARS-CoV-2 confirming prior COVID-19 diagnosis * At least 18 years of age. * Female subjects must not be pregnant or trying to become pregnant during the duration of study participation. * No known plans to move out of the state, or become unable to return to one of the Mayo Clinic sites for follow-up testing. * Must be able to provide clear informed written consent.

Exclusion criteria

* Individuals with pacemakers or other implantable devices that will make interpreting a CT scan challenging. * Individuals with major limitations to exercise.

Design outcomes

Primary

MeasureTime frameDescription
Change in diffusion capacity of the lungsthrough study completion, an average of 5 monthschange in diffusing capacity of the lungs for carbon monoxide and its components
Change in airway morphologythrough study completion, an average of 5 monthsCT assessment of airway diameter and thickness
change basic spirometrythrough study completion, an average of 5 monthsMeasurement of basic lung function using forced vital capacity (FVC), slow vital capacity (SVC), forced expiratory volume at one second (FEV1), maximal inspiratory pressure (MIPS), maximal expiratory pressure (MEPS), exhaled nitric oxide (ExNO), forced oscillation technique (FOT), overnight pulse oximetry
Change in peak aerobic capacitythrough study completion, an average of 5 monthsChange in examine post exertional malaise
Presence of post-exertional malaisethrough study completion, an average of 5 monthsEvaluation of change in performance on maximal exercise test over two days to identify presence of post-exertional malaise
Change in symptomsthrough study completion, an average of 5 monthsSt. George's respiratory Questionnaire scoring of pulmonary symptoms. Scores range from 0 to 100, with higher scores indicating more limitations.
change in quality of lifethrough study completion, an average of 5 monthsSF-36 questionnaire assessment of physical and mental health. Two scores one for physical functioning and one for mental functioning. Scores range from 0-100 with a higher score indicating better health

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026